Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Asset Writedowns and Impairment (2016 - 2026)

Apyx Medical filings provide 15 years of Asset Writedowns and Impairment readings, the most recent being $218000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 113.73% to $218000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $423000.0, a 159.51% increase, with the full-year FY2025 number at $423000.0, up 159.51% from a year prior.
  • Asset Writedowns and Impairment hit $218000.0 in Q4 2025 for Apyx Medical, up from $33000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $218000.0 in Q4 2025 to a low of -$142000.0 in Q1 2023.
  • Median Asset Writedowns and Impairment over the past 5 years was $46500.0 (2021), compared with a mean of $65400.0.
  • The widest YoY moves for Asset Writedowns and Impairment: up 12200.0% in 2023, down 201.43% in 2023.
  • Apyx Medical's Asset Writedowns and Impairment stood at $71000.0 in 2021, then plummeted by 54.93% to $32000.0 in 2022, then soared by 221.88% to $103000.0 in 2023, then fell by 0.97% to $102000.0 in 2024, then surged by 113.73% to $218000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $218000.0 (Q4 2025), $33000.0 (Q3 2025), and $144000.0 (Q2 2025) per Business Quant data.